Free Trial

Alpha Cognition (ACOG) Stock Price, News & Analysis

Alpha Cognition logo
$9.21 -0.36 (-3.76%)
As of 06/26/2025 04:00 PM Eastern

About Alpha Cognition Stock (NASDAQ:ACOG)

Key Stats

Today's Range
$8.95
$9.60
50-Day Range
$4.12
$10.57
52-Week Range
$3.75
$11.40
Volume
86,149 shs
Average Volume
90,607 shs
Market Capitalization
$147.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00
Consensus Rating
Buy

Company Overview

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Alpha Cognition Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

ACOG MarketRank™: 

Alpha Cognition scored higher than 38% of companies evaluated by MarketBeat, and ranked 736th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alpha Cognition has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Alpha Cognition has only been the subject of 1 research reports in the past 90 days.

  • Read more about Alpha Cognition's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Alpha Cognition is -7.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Alpha Cognition is -7.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Alpha Cognition has a P/B Ratio of 3.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Alpha Cognition's valuation and earnings.
  • Short Interest

    There is no current short interest data available for ACOG.
  • Dividend Yield

    Alpha Cognition does not currently pay a dividend.

  • Dividend Growth

    Alpha Cognition does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for ACOG.
  • News Sentiment

    Alpha Cognition has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.98 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Alpha Cognition this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for ACOG on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Alpha Cognition to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Alpha Cognition insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.00% of the stock of Alpha Cognition is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Alpha Cognition's insider trading history.
Receive ACOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpha Cognition and its competitors with MarketBeat's FREE daily newsletter.

ACOG Stock News Headlines

The DOJ Just Paved the Way for Account Seizures
Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.
ACOG Alpha Cognition Inc.
See More Headlines

ACOG Stock Analysis - Frequently Asked Questions

Alpha Cognition's stock was trading at $5.86 at the beginning of 2025. Since then, ACOG stock has increased by 57.2% and is now trading at $9.21.
View the best growth stocks for 2025 here
.

Alpha Cognition Inc. (NASDAQ:ACOG) announced its earnings results on Thursday, May, 15th. The company reported ($0.20) earnings per share for the quarter, topping the consensus estimate of ($0.58) by $0.38. The business earned $2.93 million during the quarter, compared to the consensus estimate of $0.50 million.
Read the conference call transcript
.

Alpha Cognition (ACOG) raised $50 million in an IPO on Tuesday, November 12th 2024. The company issued 8,695,653 shares at $5.75 per share.

Alpha Cognition's lock-up period expired on Monday, May 12th. Alpha Cognition had issued 8,695,653 shares in its IPO on November 12th. The total size of the offering was $50,000,005 based on an initial share price of $5.75. Since the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Top institutional investors of Alpha Cognition include AWM Investment Company Inc. (6.84%), Alyeska Investment Group L.P. (2.11%), Altium Capital Management LLC (1.11%) and Corsair Capital Management L.P. (0.88%).

Shares of ACOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
6/27/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ACOG
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.00
High Stock Price Target
$20.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+117.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.64 million
Pretax Margin
-397.44%

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$2.59 per share
Price / Book
3.56

Miscellaneous

Free Float
13,777,000
Market Cap
$147.54 million
Optionable
N/A
Beta
2.79
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:ACOG) was last updated on 6/27/2025 by MarketBeat.com Staff
From Our Partners